428 related articles for article (PubMed ID: 25684565)
1. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
[TBL] [Abstract][Full Text] [Related]
2. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
Kupari M; Laine M; Turto H; Lommi J; Werkkala K
J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
[TBL] [Abstract][Full Text] [Related]
3. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
[TBL] [Abstract][Full Text] [Related]
4. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.
López B; González A; Querejeta R; Larman M; Rábago G; Díez J
Hypertension; 2014 Mar; 63(3):483-9. PubMed ID: 24366078
[TBL] [Abstract][Full Text] [Related]
5. Effect of High Thoracic Sympathetic Nerve Block on Serum Collagen Biomarkers in Patients with Chronic Heart Failure.
Sun G; Liu F; Qu R
Cardiology; 2017; 136(2):102-107. PubMed ID: 27591776
[TBL] [Abstract][Full Text] [Related]
6. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
[TBL] [Abstract][Full Text] [Related]
7. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
Kobayashi M; Girerd N; Ferreira JP; Kevin D; Huttin O; González A; Bozec E; Clark AL; Cosmi F; Cuthbert J; Diez J; Edelmann F; Hazebroek M; Heymans S; Mariottoni B; Pellicori P; Petutschnigg J; Pieske B; Staessen JA; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1559-1568. PubMed ID: 35703355
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
TORAFIC Investigators Group
Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
[TBL] [Abstract][Full Text] [Related]
9. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
[TBL] [Abstract][Full Text] [Related]
10. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients.
Lin YH; Shiau YC; Yen RF; Lin LC; Wu CC; Ho YL; Huang PJ
Ultrasound Med Biol; 2004 Jul; 30(7):885-91. PubMed ID: 15313321
[TBL] [Abstract][Full Text] [Related]
11. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
[TBL] [Abstract][Full Text] [Related]
12. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
[TBL] [Abstract][Full Text] [Related]
13. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.
Besler C; Lang D; Urban D; Rommel KP; von Roeder M; Fengler K; Blazek S; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28288987
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
[TBL] [Abstract][Full Text] [Related]
15. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
Kaye DM; Khammy O; Mariani J; Maeder MT
Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
[TBL] [Abstract][Full Text] [Related]
16. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot.
Lai CT; Chan KW; Wong SJ; Chow PC; Cheung YF
Am Heart J; 2011 Sep; 162(3):467-73. PubMed ID: 21884862
[TBL] [Abstract][Full Text] [Related]
18. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
[TBL] [Abstract][Full Text] [Related]
19. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.
Ferreira JP; Rossignol P; Pizard A; Machu JL; Collier T; Girerd N; Huby AC; Gonzalez A; Diez J; López B; Sattar N; Cleland JG; Sever PS; Zannad F
Heart; 2019 Feb; 105(4):307-314. PubMed ID: 30121630
[TBL] [Abstract][Full Text] [Related]
20. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]